US National Institutes of Health: Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) seeks to stimulate research on mid-life adults (those 50 to 64 years of age) that can inform efforts to optimise health and well-being as individuals age and prevent illness and disability in later years.

The R21 Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects.

Funding Opportunity Announcement (FOA) Number: PA-18-850

Companion Schemes

Funding & Duration

The combined budget for direct costs for the two year project period may not exceed USD $275,000 (approx. AUD $371,000).

The maximum project period is 2 years.


Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Submission Requirements & Due Date

Further Information

Need Help?

This entry was posted in Arts, Engineering, Computer & Mathematical Sciences, Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding and tagged . Bookmark the permalink.

Comments are closed.